A reversible male contraceptive agent
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

BHD

Item No. 38962

Technical Information
Formal Name
4-[1-[(2,4-dichlorophenyl)methyl]-1H-indazol-3-yl]-benzoic acid hydrazide
CAS Number
2749517-98-2
Molecular Formula
C21H16Cl2N4O
Formula Weight
Purity
≥98%
A solid
DMF: 20 mg/mlDMSO: 10 mg/ml
SMILES
ClC(C=C1Cl)=CC=C1CN2C3=CC=CC=C3C(C4=CC=C(C(NN)=O)C=C4)=N2
InChi Code
InChI=1S/C21H16Cl2N4O/c22-16-10-9-15(18(23)11-16)12-27-19-4-2-1-3-17(19)20(26-27)13-5-7-14(8-6-13)21(28)25-24/h1-11H,12,24H2,(H,25,28)
InChi Key
LIQIGECRYHVIPC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    BHD is a reversible male contraceptive agent.1 In vivo, BHD (100 and 500 mg/kg) induces spermatogenic cell apoptosis and seminiferous tubule abnormalities, disrupts the blood-testis barrier, and reduces the fertility index in male mice for a duration of two to six weeks post-administration.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Gong, S., Zhu, S., Zhou, P., et alDiscovering a reversible male contraceptive agent derived from lonidamine. ACS Omega 8(20), 18245-18254 (2023).